Table 2:

Baseline group characteristics

Shielding GroupMean FT (min)Mean PKA (Gy × cm2)Mean Patient BMIIntervention/Diagnostic
R0L041.63148.4325.912/18
R1L037.38138.6429.749/21
R0L154.08164.1129.4814/16
R1L145.17145.7427.3514/15
  • Note:—FT indicates fluoroscopy time; R0L1, standard lead shielding; R0L0, no shielding; R1L0, use of the RADPAD drape; R1L1, concomitant use of the 2 shielding systems together.